Literature DB >> 12089239

Safety issues of soy phytoestrogens in breast cancer patients.

Mário De Lemos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12089239     DOI： 10.1200/JCO.2002.20.13.3040

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

Review 1.  Role of phytoestrogens in cancer therapy.

Authors:  Mandeep K Virk-Baker; Tim R Nagy; Stephen Barnes
Journal:  Planta Med       Date:  2010-07-01       Impact factor: 3.352

2.  Bioactivity of isoflavones: assessment through a theoretical model as a way to obtain a "Theoretical Efficacy Related to Estradiol (TERE)".

Authors:  Maria da Graça R Campos; Miguel Pires Matos
Journal:  Int J Mol Sci       Date:  2010-02-02       Impact factor: 5.923

3.  Potential of chemotherapy-herb interactions in adult cancer patients.

Authors:  Jeannine S McCune; Amy J Hatfield; Anne A R Blackburn; Patricia O Leith; Robert B Livingston; Georgiana K Ellis
Journal:  Support Care Cancer       Date:  2004-02-27       Impact factor: 3.603

Review 4.  Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.

Authors:  Mark J Messina; Charles E Wood
Journal:  Nutr J       Date:  2008-06-03       Impact factor: 3.271
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.